A Phase II Study of AS1411 in Renal Cell Carcinoma

NCT00740441 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: AS1411

Sponsor

Antisoma Research